erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the . january 2014  (16) . .

�long delays can put people under incredible stress at an already difficult time and could also mean that someone�s health could take a turn for the worse. .

.